Twin Tree Management, LP Novartis Ag Call Options Transaction History

Twin Tree Management, LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $36.9 Million - $42.9 Million	451,000 Added 961.62%	497,900 $40.7 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $5 Million - $5.9 Million	-59,900 Reduced 56.09%	46,900 $4.01 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $8.29 Million - $10 Million	106,200 Added 17700.0%	106,800 $10.1 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $995,439 - $1.12 Million	-12,300 Reduced 95.35%	600 $52,000
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $128,310 - $141,390	1,500 Added 13.16%	12,900 $1.12 Million
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $188,058 - $201,864	2,600 Added 29.55%	11,400 $957,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $652,432 - $679,976	8,800	8,800 $755,000

1,423

130M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.